Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JWN
Nordstrom
JWN
|
+$5.28M |
| 2 |
Microsoft
MSFT
|
+$5.26M |
| 3 |
AT&T
T
|
+$5.19M |
| 4 |
Biogen
BIIB
|
+$5.03M |
| 5 |
CVS Health
CVS
|
+$5M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.73% |
| 2 | Consumer Staples | 13.08% |
| 3 | Consumer Discretionary | 12.51% |
| 4 | Financials | 10.61% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
1
DELISTED
Nordstrom
JWN
| $5.84M | 4.14% |
+142,710
| New | +$5.28M |
|
|
2
Microsoft
MSFT
$3.59T
| $5.65M | 4% |
+35,802
| New | +$5.26M |
|
3
Bristol-Myers Squibb
BMY
$137B
| $5.56M | 3.94% |
+86,641
| New | +$4.96M |
|
|
4
Biogen
BIIB
$32B
| $5.38M | 3.81% |
+18,114
| New | +$5.03M |
|
|
5
AT&T
T
$173B
| $5.31M | 3.76% |
+179,748
| New | +$5.19M |
|
|
6
CVS Health
CVS
$119B
| $5.29M | 3.75% |
+71,206
| New | +$5M |
|
|
K
7
DELISTED
Kellanova
K
| $5.18M | 3.67% |
+79,702
| New | +$4.83M |
|
8
Amazon
AMZN
$2.79T
| $5.1M | 3.61% |
+55,200
| New | +$4.89M |
|
9
Kraft Heinz
KHC
$30.3B
| $5.1M | 3.61% |
+158,647
| New | +$4.8M |
|
10
Wells Fargo
WFC
$254B
| $5.08M | 3.6% |
+94,359
| New | +$4.94M |
|
|
SRCL
11
DELISTED
Stericycle Inc
SRCL
| $5M | 3.54% |
+78,280
| New | +$4.63M |
|
12
Compass Minerals
CMP
$1.09B
| $4.98M | 3.53% |
+81,735
| New | +$4.64M |
|
13
Goldman Sachs
GS
$303B
| $4.8M | 3.4% |
+20,861
| New | +$4.53M |
|
14
Simon Property Group
SPG
$70.6B
| $4.74M | 3.36% |
+31,793
| New | +$4.77M |
|
15
AB InBev
BUD
$155B
| $4.71M | 3.34% |
+57,477
| New | +$4.79M |
|
16
ExxonMobil
XOM
$679B
| $4.62M | 3.27% |
+66,171
| New | +$4.58M |
|
17
Bank of America
BAC
$431B
| $4.59M | 3.25% |
+130,243
| New | +$4.21M |
|
18
Enterprise Products Partners
EPD
$82.1B
| $4.58M | 3.25% |
+162,821
| New | +$4.41M |
|
19
McDonald's
MCD
$192B
| $3.35M | 2.37% |
+16,927
| New | +$3.36M |
|
20
Verizon
VZ
$205B
| $3.33M | 2.36% |
+54,219
| New | +$3.27M |
|
21
Pfizer
PFE
$160B
| $3.28M | 2.32% |
+88,227
| New | +$3.14M |
|
22
Intel
INTC
$476B
| $3.24M | 2.3% |
+54,198
| New | +$3.03M |
|
23
Merck
MRK
$376B
| $3.23M | 2.29% |
+37,161
| New | +$3.05M |
|
24
Nike
NKE
$60.5B
| $3.17M | 2.25% |
+31,302
| New | +$2.95M |
|
25
IBM
IBM
$222B
| $3.12M | 2.21% |
+24,373
| New | +$3.17M |
|
Similar funds
Mark Hillman's Q4 2019 Portfolio in Review
As of Q4 2019, Mark Hillman held 50 positions worth $141M. Its ten largest holdings account for 38% of the portfolio.
Mark Hillman deployed $135M of net new capital in Q4 2019, opening 50 new positions. Its largest new stake was Nordstrom: 142,710 shares worth $5.84M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Consumer Staples and Consumer Discretionary.
- Mark Hillman's largest Q4 2019 buy was Nordstrom: 142,710 shares worth $5.84M.
- Mark Hillman's ten largest holdings make up 38% of its $141M portfolio in Q4 2019.
- Mark Hillman opened 50 new positions and closed 0 in Q4 2019.
Based on Hillman Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.